Novel pharmacology of cannabidivarin, tetrahydrocannabivarin, cannabigerol, and cannabichromene in vitro and in vivo

被引：0
|
作者：
Laprairie, Robert [1 ]
Mohamed, Kawthar [1 ]
Kim, David [1 ]
Zagzoog, Ayat [1 ]
机构：
[1] Univ Saskatchewan, Saskatoon, SK, Canada
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2020年 / 177卷 / 11期
关键词：
THC;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P228
引用
收藏
页码：2626 / 2627
页数：2
相关论文
共 50 条
  • [41] SE 214857: A novel nm peptide orally active potent and selective platelet GPIIb/IIIa receptor antagonist: In vitro and in vivo pharmacology
    Feuerstein, G
    Wong, A
    Nichols, A
    Samanen, J
    Stadel, JM
    VaskoMoser, J
    Koster, P
    Valocik, R
    CIRCULATION, 1996, 94 (08) : 3007 - 3007
  • [42] Synthesis, in vitro and in vivo pharmacology of substituted 1,2-dihydrophthalazine AMPA antagonists: Identification of SYM 2206 as a novel anticonvulsant.
    Pelletier, JC
    Hesson, DP
    Collins, MA
    Jones, KA
    MariaCosta, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 110 - MEDI
  • [43] KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology
    Wang, Wei
    Ao, Lin
    Rayburn, Elizabeth R.
    Xu, Hongxia
    Zhang, Xiangrong
    Zhang, Xu
    Nag, Subhasree Ashok
    Wu, Xuming
    Wang, Ming-Hai
    Wang, Hui
    Van Meir, Erwin G.
    Zhang, Ruiwen
    PLOS ONE, 2012, 7 (09):
  • [44] Network pharmacology analysis of the regulatory effects and mechanisms of ALAE on sow reproduction in vivo and in vitro
    Zhao, Linlu
    Zhang, Jin
    He, Jieyi
    Guo, Mengru
    Wu, Huining
    Ma, Xingbin
    Yu, Zhichao
    Yong, Yanhong
    Li, Youquan
    Ju, Xianghong
    Liu, Xiaoxi
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 334
  • [45] Adhesion G Protein-Coupled Receptors: From In Vitro Pharmacology to In Vivo Mechanisms
    Monk, Kelly R.
    Hamann, Joerg
    Langenhan, Tobias
    Nijmeijer, Saskia
    Schoeneberg, Torsten
    Liebscher, Ines
    MOLECULAR PHARMACOLOGY, 2015, 88 (03) : 617 - 623
  • [46] How to Choose In Vitro Systems to Predict In Vivo Drug Clearance: A System Pharmacology Perspective
    Wang, Lei
    Chiang, ChienWei
    Liang, Hong
    Wu, Hengyi
    Feng, Weixing
    Quinney, Sara K.
    Li, Jin
    Li, Lang
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [47] In vivo pharmacology of a-798: A novel melanin concentrating hormone receptor antagonist
    Bush, E
    Fey, T
    Dickinson, R
    Shapiro, R
    Knourek-Segel, V
    Droz, B
    Mcdowell, C
    Jacobson, P
    Nuss, M
    Souers, A
    Iyengar, R
    Kym, P
    Collins, C
    Brune, M
    OBESITY RESEARCH, 2004, 12 : A14 - A14
  • [48] In vitro and in vivo pharmacology of the novel, orally active GPIIbIIIa-antagonist EMD 122 347 and its active drug EMD 132 338
    BernotatDanielowski, S
    Melzer, G
    Rohmann, S
    Haunschild, J
    Gante, J
    Juraszyk, H
    Wurziger, H
    THROMBOSIS AND HAEMOSTASIS, 1997, : O1601 - O1601
  • [49] Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy
    Thompson, CF
    Quraishi, N
    Ali, A
    Tata, JR
    Hammond, ML
    Balkovec, JM
    Einstein, M
    Ge, L
    Harris, G
    Kelly, TM
    Mazur, P
    Pandit, S
    Santoro, J
    Sitlani, A
    Wang, CL
    Williamson, J
    Miller, DK
    Yamin, TTD
    Thompson, CM
    O'Neill, EA
    Zaller, D
    Forrest, MJ
    Carballo-Jane, E
    Luell, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (08) : 2163 - 2167
  • [50] In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin
    Devader, C.
    Khayachi, A.
    Veyssiere, J.
    Maati, H. Moha Ou
    Roulot, M.
    Moreno, S.
    Borsotto, M.
    Martin, S.
    Heurteaux, C.
    Mazella, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (10) : 2604 - 2617
12345